Taylor Wealth Management Partners Krystal Biotech, Inc. Transaction History
Taylor Wealth Management Partners
- $176 Million
- Q2 2022
A detailed history of Taylor Wealth Management Partners transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Taylor Wealth Management Partners holds 4,514 shares of KRYS stock, worth $873,097. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,514
Previous 5,365
15.86%
Holding current value
$873,097
Previous $357,000
17.09%
% of portfolio
0.17%
Previous 0.14%
Shares
6 transactions
Others Institutions Holding KRYS
# of Institutions
262Shares Held
21.5MCall Options Held
462KPut Options Held
723K-
Avoro Capital Advisors LLC New York, NY2.56MShares$494 Million5.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$471 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$349 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.51MShares$292 Million10.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$191 Million9.23% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.96B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...